Portal CEO, John Flavin, recently sat down with Institutional Investor to discuss why large-scale investors love our life sciences investment model. Take a look!
Stay up-to-date on the latest VC, biotech, and med tech news in Chicago and across the U.S. Sign up with your email address below to get our monthly newsletter delivered to your inbox!